Amyloid Fluorescence Lifetime Analysis for Rapid Polymorphism Identification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for identifying the structural polymorphism of fibrous proteins or peptides, such as amyloid, are costly and time-consuming, with cryo-electron microscopy and solid-state nuclear magnetic resonance techniques requiring significant resources and taking months to complete.
Innovation Solution
A method involving fluorescence decay analysis of thioflavin T (ThT) bound to amyloid fibers, separating the fluorescence decay curve into exponential components to derive fluorescence lifetime values and weighting factors, allowing for rapid identification of structural polymorphism through exponential fitting and comparison with a database.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If cryo-electron microscopy is used to identify structural polymorphism of amyloid, then measurement precision is improved, but measurement time increases to 1-2 months and cost increases
Solution Approach 1:
The patent replaces the mechanical/cryogenic electron microscopy system with a fluorescence-based optical system. By using thioflavin T fluorescence lifetime measurement, the method substitutes complex mechanical imaging with a simpler optical detection approach that provides sufficient precision for structural polymorphism identification while dramatically reducing measurement time to minutes.
Solution Approach 2:
The patent changes the measurement parameter from structural imaging (cryo-EM) to fluorescence lifetime characteristics. By measuring the fluorescence lifetime of thioflavin T bound to different amyloid structures and analyzing the exponential decay components, the method identifies structural polymorphisms through spectral parameter differences rather than direct structural imaging, achieving both speed and accuracy.
2Measurement precision
If solid state nuclear magnetic resonance is used to identify structural polymorphism of amyloid, then measurement precision is improved, but measurement time increases to several weeks and cost increases
Solution Approach 1:
The patent replaces the complex nuclear magnetic resonance system with a fluorescence-based optical system. This substitution eliminates the need for expensive NMR instrumentation and lengthy measurement protocols, achieving comparable structural differentiation through fluorescence lifetime analysis that completes in minutes rather than weeks.
Solution Approach 2:
The patent employs a simple, inexpensive fluorescence measurement approach using thioflavin T dye and standard fluorescence equipment. This disposable-like simplicity in methodology (compared to the expensive, complex NMR setup) enables rapid, high-throughput screening of multiple amyloid samples without the resource constraints of NMR.
3Productivity
If fluorescence decay analysis with ThT is used to identify structural polymorphism, then measurement time is reduced to minutes, but measurement precision must be maintained through multi-component exponential fitting
Solution Approach 1:
The patent segments the fluorescence decay curve into multiple exponential components, each representing ThT bound to different amyloid binding sites or structures. By analyzing the weighted sum of these segmented exponential decays with distinct lifetime values, the method extracts structural polymorphism information while maintaining computational tractability through systematic fitting procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables quick and cost-effective identification of structural polymorphism of fibrous proteins or peptides, reducing measurement time from weeks or months to a more manageable duration.
Implementation Method 1
obtaining a fluorescence decay curve for a sample containing a fibrous protein or peptide and thioflavin T
Data Source
AI summary
A method for identifying a structural polymorphism of a fibrous protein or peptide, the method including the steps of: obtaining a fluorescence decay curve for a sample containing a fibrous protein or peptide and thioflavin T; performing exponential fitting of four or more components based on a specific function G(t) on a function F(t) of the fluorescence decay curve to obtain fluorescence lifetime values τ1 to τn and weighting factors A1 to An (n is a natural number of 4 or more) of the respective exponential components; and identifying the structural polymorphism of the fibrous protein or peptide based on at least one or more values of the fluorescence lifetime values τ1 to τn and at least one or more values of the weighting factors A1 to An (a fluorescence lifetime value and a weighting factor in an exponential component derived from autofluorescence of thioflavin T are excluded).